The corresponding network derived from immune and endothelial cell signaling is considerably smaller than the networks comparing COVID-19 patients to healthy controls (Figures 3, 4) and no direct regulatory effects for the glycocalyx components or ADAMTS13 can be identified (Figure 5). The gene discussed is ADAMTS13; the disease is COVID-19.